Suppr超能文献

肺表面活性物质联合大剂量盐酸氨溴索治疗新生儿呼吸窘迫综合征的疗效

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome.

作者信息

Xiang Jiajun, Wang Ping

机构信息

Department of Paediatrics, Linyi Central Hospital, Linyi, Shandong 276400, P.R. China.

Department of Operation, Linyi Central Hospital, Linyi, Shandong 276400, P.R. China.

出版信息

Exp Ther Med. 2019 Jul;18(1):654-658. doi: 10.3892/etm.2019.7615. Epub 2019 May 24.

Abstract

Clinical efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome (NRDS) was investigated. One hundred child patients with NRDS in Linyi Central Hospital were collected according to the diagnostic criteria for RDS in the Pediatrics, and randomly divided into the treatment group (n=50) and the control group (n=50) based on different therapeutic methods. Patients in the control group were treated with basic treatment and high-dose ambroxol hydrochloride injection, while those in the treatment group were additionally administered with pulmonary surfactant Curosurf based on conventional therapy in the control group. The chest X-rays were collected before the treatment and at 12 h after the drug administration, the degree of respiratory distress in child patients was observed and evaluated via Silverman grading, and changes in blood gas indexes were recorded before treatment and at 2, 6 and 12 h after the drug administration. The chest X-ray grade, Silverman grade and blood gas analysis results had no differences between the two groups before the treatment (P>0.05). In the treatment group, partial pressure of oxygen (PaO) and PH were increased and partial pressure of carbon dioxide (PaCO) was decreased compared with those in the control group at 2, 6 and 12 h after the drug administration (P<0.05). At 12 h after the drug administration, chest X-ray grade and Silverman grade in both groups were improved, which were significantly superior in the treatment group to those in the control group (P<0.01). Moreover, the efficacy in the treatment group was remarkably better than that in the control group at 12 h after drug administration (P<0.01). Pulmonary surfactant combined with high-dose ambroxol hydrochloride has definite efficacy in the treatment of NRDS, which can significantly improve the pulmonary infection, respiratory distress and blood gas indexes of child patients.

摘要

探讨肺表面活性物质联合大剂量盐酸氨溴索治疗新生儿呼吸窘迫综合征(NRDS)的临床疗效。按照《儿科学》中RDS的诊断标准,收集临沂市中心医院100例NRDS患儿,根据不同治疗方法随机分为治疗组(n = 50)和对照组(n = 50)。对照组采用基础治疗及大剂量盐酸氨溴索注射液治疗,治疗组在对照组常规治疗基础上额外给予肺表面活性物质珂立苏。分别于治疗前及给药后12 h采集胸部X线片,采用Silverman评分法观察并评估患儿呼吸窘迫程度,记录治疗前及给药后2、6、12 h血气指标变化。治疗前两组患儿胸部X线分级、Silverman评分及血气分析结果比较,差异无统计学意义(P > 0.05)。给药后2、6、12 h,治疗组患儿氧分压(PaO)及pH值升高,二氧化碳分压(PaCO)降低,与对照组比较差异有统计学意义(P < 0.05)。给药后12 h,两组患儿胸部X线分级及Silverman评分均有所改善,治疗组改善程度明显优于对照组(P < 0.01)。此外,给药后12 h治疗组疗效明显优于对照组(P < 0.01)。肺表面活性物质联合大剂量盐酸氨溴索治疗NRDS疗效确切,可显著改善患儿肺部感染、呼吸窘迫及血气指标。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验